AlphaYou
Overview
No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.
Key stats
Aug 21- Open
- $256.65
- 52-wk high
- $282.15
- High
- $260.98
- 52-wk low
- $186.05
- Low
- $253.21
- Prev close
- $259.62
Smart money
Earnings
Earnings came in $2.51 a share above what analysts expected.
Financials
What it sold, what it cost, what was left.
Jun 2024Sep 2024Mar 2025
| USD | Jun 2024 | Sep 2024 | Mar 2025 |
|---|---|---|---|
| What came in | |||
| Revenue | $36.0M | $57.8M | $101.0M |
| Cost of what it sold | $11.5M | $11.2M | $17.5M |
| Gross profit | $24.5M | $46.6M | $83.4M |
| What it spent | |||
| Research and development | $83.5M | $73.5M | $86.6M |
| Sales and admin | $72.3M | $68.1M | $95.6M |
| Other operating costs | $2.0M | $1.7M | $5.4M |
| Total operating expenses | $157.8M | $143.4M | $187.6M |
| What was left | |||
| Operating profit | -$133.3M | -$96.7M | -$104.2M |
| Interest on debt | $19.6M | $25.3M | $44.8M |
| Profit before tax | -$109.2M | -$98.2M | -$93.6M |
| Tax | $229.0K | $1.0M | $1.1M |
| Net profit | -$109.4M | -$99.2M | -$94.6M |
| EBITDA | -$87.5M | -$71.1M | -$44.2M |
Technicals
Price structure
This stock is in a strong uptrend.
Trend
Strong uptrend
100 / 100
RSI 14
62balanced
20D volatility
27%annualized
52-week range
$186.05$282.15
20D support
News
What the news says
21 articles · 7 days
Coverage is bullish
Tone of tracked coverage
Ascendis Pharma A/S Just Recorded A 104% EPS Beat: Here's What Analysts Are Forecasting Next
BullishAug 16Ascendis Pharma A/S (NASDAQ:ASND) Upgraded at Wall Street Zen
Leans bullishAug 15Ascendis Pharma A/S (NASDAQ:ASND) Releases Quarterly Earnings Results, Misses Estimates By $0.68 EPS
Neutral